U.S. markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,781.90
    -23.60 (-1.31%)
     
  • Silver

    22.64
    -0.81 (-3.44%)
     
  • EUR/USD

    1.1965
    +0.0051 (+0.43%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • GBP/USD

    1.3304
    -0.0052 (-0.39%)
     
  • USD/JPY

    104.0740
    -0.1760 (-0.17%)
     
  • BTC-USD

    16,968.71
    +243.91 (+1.46%)
     
  • CMC Crypto 200

    332.12
    -5.38 (-1.59%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Cancer Genetics: 3Q Earnings Snapshot

·1 min read

RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Thursday reported a third-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 58 cents.

The diagnostics company posted revenue of $1.6 million in the period.

In the final minutes of trading on Thursday, the company's shares hit $2.21. A year ago, they were trading at $3.11.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX